Temozolomide

본문 바로가기


Home > Product > Temozolomide
Selling leads
Temozolomide
Posting date : Jul 22, 2025
Membership
Free Member Scince Jun 27, 2025
FOB Price
detailed discussion
Min. Order Quantity
1
Supply Abillity
hundreds of kgs
Port
Shanghai Port
Payment Terms
detailed discussion
Package
Convenient package
Keyword :
Category
Contact
Lena
Selling Leads Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
Royal
Model Number
+86 15242851296
HS-CODE
-
Package & Delivery Lead Time
Package
Convenient package
Detailed Description

Temozolomide is the first orally effective imidazotetrazine antitumor drug, belonging to the second-generation alkylating agents with anti-tumor activity. It does not require hepatic metabolic activation after oral administration. Its characteristics include easy passage through the blood-brain barrier, good tolerance, and no supertoxicity with other Chemicalbook drugs. It also has a synergistic effect with radiotherapy. It is applicable to malignant gliomas that recur after conventional treatment, such as glioblastoma multiformis or degenerative astrocytoma, and is also the first-line drug for the treatment of metastatic melanoma


ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2026 ECROBOT.COM. All rights reserved.
Top